This is the authors' abstract. We don't add key points for this paper.
We describe a patient with the previously unreported association of chronic inflammatory demyelinating polyneuropathy (CIDP) and myasthenia gravis (MG). Immunosuppressive treatment with azathioprine and prednisone achieved clinical and electrophysiological remission of MG and improvement of CIDP. As ophthalmoplegia occurs infrequently in CIDP, the possibility of MG should be considered when this sign is present in a patient with CIDP. Since current therapy with corticosteroids, plasma exchange and other immunomodulating agents is effective against both diseases, their association may be undereported.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sempere et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: